Related Experiment Videos
Effect of levamisole and azathioprine on the human mixed lymphocyte reaction (MLR)
British Journal of Clinical Pharmacology
|July 1, 1984
Abstract:
Levamisole (1.25-4.15 microM) had no effect on tritiated thymidine incorporation into DNA of mixed lymphocyte cultures. Moreover, it did not cause any reversal of azathioprine (18-36 microM) inhibitory effects on the MLR.
Insights
Levamisole did not impact DNA synthesis in mixed lymphocyte cultures. It also failed to reverse the inhibitory effects of azathioprine on this immune response.
Area of Science:
- Immunology
- Pharmacology
Background:
- Mixed lymphocyte culture (MLC) is a key model for studying T-cell mediated immune responses.
- Levamisole is an immunomodulatory drug with a complex history of use.
- Azathioprine is an immunosuppressive drug commonly used in transplantation and autoimmune diseases.
Purpose of the Study:
- To investigate the direct effects of Levamisole on DNA synthesis in MLC.
- To determine if Levamisole can counteract the immunosuppressive action of Azathioprine in MLC.
Main Methods:
- Mixed lymphocyte cultures were established.
- Tritiated thymidine incorporation into DNA was measured to assess lymphocyte proliferation.
- Cultures were treated with varying concentrations of Levamisole and/or Azathioprine.
Main Results:
- Levamisole (1.25-4.15 microM) demonstrated no significant effect on tritiated thymidine incorporation into DNA.
- Levamisole did not reverse the inhibitory effects of Azathioprine (18-36 microM) on the mixed lymphocyte response.
Conclusions:
- Levamisole does not directly stimulate or inhibit DNA synthesis in human T-cells within the tested concentration range.
- Levamisole does not possess immunostimulatory properties that can overcome Azathioprine-induced immunosuppression in this in vitro model.